Development and Validation of a Model to Predict Long‐Term Survival After Liver Transplantation

David Goldberg, Alejandro Mantero, Craig Newcomb, Cindy Delgado, Kimberly Forde, David Kaplan, Binu John, Nadine Nuchovich, Barbara Dominguez, Ezekiel Emanuel, Peter P. Reese – 3 February 2021 – Patients are prioritized for liver transplantation (LT) under an “urgency‐based” system using the Model for End‐Stage Liver Disease score. This system focuses solely on waitlist mortality, without considerations of posttransplant morbidity, mortality, and health care use. We sought to develop and internally validate a continuous posttransplant risk score during 5‐year and 10‐year time horizons.

Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria

Manhal Izzy, Anna Soldatova, Xin Sun, Mounika Angirekula, Kristin Mara, Grace Lin, Kymberly D. Watt – 2 February 2021 – The diagnostic criteria for cirrhotic cardiomyopathy (CCM) were recently revised to reflect the contemporary advancements in echocardiographic technology. This study evaluates the prevalence of CCM, according to the new criteria, and its impact on posttransplant cardiovascular disease (CVD). This is a single‐center retrospective matched cohort study of liver transplantation (LT) recipients who underwent LT between January 1, 2008 and November 30, 2017.

Subscribe to